Carcinogenesis, Vol 18, 511-516, Copyright © 1997 by Oxford University Press
M Hollstein, H Bartsch, H Wesch, EH Kure, R Mustonen, KR Muhlbauer, A Spiethoff, K Wegener, T Wiethege and KM Muller
The p53 gene was examined for point mutations in archived, alpha-
radiation-associated lung and liver cancers. Lung tumors of 50 uranium
miners in Germany were screened by restriction fragment length analysis for
the putative hotspot mutation at codon 249 (Arg-->Met) previously
detected in a significant fraction of miners from the Colorado Plateau,
USA. This mutation has been proposed as a marker of radon exposure. None of
the tumors we examined harbored the hotspot mutation. Five of the 50
tumors, however, did indeed harbor exon 7 mutations, as determined by
subsequent mutation analysis of exon 7. These mutations were dispersed
among various codons and may be attributable to heavy tobacco smoking in
this cohort. In support of this interpretation, we found no mutations in
exons 5-8 of the p53 gene in 13 iatrogenic liver cancers induced by
injection of Thorotrast, an alpha-emitting radiocontrast agent. We propose
that if the p53 tumor suppressor gene is a target for the carcinogenic
action of alpha-particle radiation, loss of suppressor function may occur
preferentially by mechanisms such as intrachromosomal deletions, rather
than by base substitution mutations.
ARTICLES
p53 gene mutation analysis in tumors of patients exposed to alpha- particles
Division of Toxicology and Cancer Risk Factors, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. M. Rudin, E. Avila-Tang, C. C. Harris, J. G. Herman, F. R. Hirsch, W. Pao, A. G. Schwartz, K. H. Vahakangas, and J. M. Samet Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications Clin. Cancer Res., September 15, 2009; 15(18): 5646 - 5661. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ruano-Ravina, R. Perez-Becerra, M. Fraga, K. T. Kelsey, and J. M. Barros-Dios Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure Ann. Onc., January 1, 2008; 19(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Iwamoto, S. Fujii, A. Kurata, M. Suzuki, T. Hayashi, Y. Ohtsuki, Y. Okada, M. Narita, M. Takahashi, S. Hosobe, et al. p53 mutations in tumor and non-tumor tissues of Thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver Carcinogenesis, July 1, 1999; 20(7): 1283 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yngveson, C. Williams, A. Hjerpe, J. Lundeberg, P. Söderkvist, and G. Pershagen p53 Mutations in Lung Cancer Associated with Residential Radon Exposure Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 433 - 438. [Abstract] [Full Text] |
||||



